Literature DB >> 24976370

Review: [corrected] The changing face of the HIV epidemic in sub-Saharan Africa.

Portia C Mutevedzi1, Marie-Louise Newell.   

Abstract

The widespread roll-out of antiretroviral therapy (ART) has substantially changed the face of human immunodeficiency virus (HIV). Timely initiation of ART in HIV-infected individuals dramatically reduces mortality and improves employment rates to levels prior to HIV infection. Recent findings from several studies have shown that ART reduces HIV transmission risk even with modest ART coverage of the HIV-infected population and imperfect ART adherence. While condoms are highly effective in the prevention of HIV acquisition, they are compromised by low and inconsistent usage; male medical circumcision substantially reduces HIV transmission but uptake remains relatively low; ART during pregnancy, delivery and breastfeeding can virtually eliminate mother-to-child transmission but implementation is challenging, especially in resource-limited settings. The current HIV prevention recommendations focus on a combination of preventions approach, including ART as treatment or pre- or post-exposure prophylaxis together with condoms, circumcision and sexual behaviour modification. Improved survival in HIV-infected individuals and reduced HIV transmission risk is beginning to result in limited HIV incidence decline at population level and substantial increases in HIV prevalence. However, achievements in HIV treatment and prevention are threatened by the challenges of lifelong adherence to preventive and therapeutic methods and by the ageing of the HIV-infected cohorts potentially complicating HIV management. Although current thinking suggests prevention of HIV transmission through early detection of infection immediately followed by ART could eventually result in elimination of the HIV epidemic, controversies remain as to whether we can treat our way out of the HIV epidemic.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  ART; TAR; TasP; VIH; antiretroviral therapy; human immunodeficiency virus; incidence; incidencia; mortalidad; mortality; mortalité; prevalence; prevalencia; prevención; prevention; prévalence; prévention; traitement préventif; tratamiento como prevención; treatment as prevention

Mesh:

Substances:

Year:  2014        PMID: 24976370     DOI: 10.1111/tmi.12344

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  18 in total

1.  Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013-2014.

Authors:  Rachel A Silverman; Ingrid A Beck; Catherine Kiptinness; Molly Levine; Ross Milne; Christine J McGrath; Steve Bii; Barbra A Richardson; Grace John-Stewart; Bhavna Chohan; Samah R Sakr; James N Kiarie; Lisa M Frenkel; Michael H Chung
Journal:  J Infect Dis       Date:  2017-12-19       Impact factor: 5.226

2.  Teachers' patterns of implementation of an evidence-based intervention and their impact on student outcomes: results from a nationwide dissemination over 24-months follow-up.

Authors:  Bonita Stanton
Journal:  AIDS Behav       Date:  2015-10

3.  Despite Access to Antiretrovirals for Prevention and Treatment, High Rates of Mortality Persist Among HIV-infected Infants and Young Children.

Authors:  Elaine J Abrams; Selamawit Woldesenbet; Juliana Soares Silva; Ashraf Coovadia; Viviane Black; Karl-Günter Technau; Louise Kuhn
Journal:  Pediatr Infect Dis J       Date:  2017-06       Impact factor: 2.129

4.  HIV treatment cascade for older adults in rural South Africa.

Authors:  Julia K Rohr; Jennifer Manne-Goehler; Francesc Xavier Gómez-Olivé; Ryan G Wagner; Molly Rosenberg; Pascal Geldsetzer; Chodziwadziwa Kabudula; Kathleen Kahn; Stephen Tollman; Till Bärnighausen; Joshua A Salomon
Journal:  Sex Transm Infect       Date:  2019-06-26       Impact factor: 3.519

5.  Infectious disease consultations at a South African academic hospital: A 6-month assessment of inpatient consultations.

Authors:  Lauren Richards; David C Spencer; Jeremy S Nel; Prudence Ive
Journal:  S Afr J Infect Dis       Date:  2020-09-09

6.  How to "Live a Good Life": Aging and HIV Testing in Rural South Africa.

Authors:  Enid Schatz; Brian Houle; Sanyu A Mojola; Nicole Angotti; Jill Williams
Journal:  J Aging Health       Date:  2018-01-10

7.  ART access-related barriers faced by HIV-positive persons linked to care in southern Ghana: a mixed method study.

Authors:  Augustine Ankomah; John Kuumuori Ganle; Margaret Yaa Lartey; Awewura Kwara; Priscilla Awo Nortey; Michael Perry Kweku Okyerefo; Amos Kankponang Laar
Journal:  BMC Infect Dis       Date:  2016-12-07       Impact factor: 3.090

Review 8.  The Interaction between Human Immunodeficiency Virus and Human Papillomaviruses in Heterosexuals in Africa.

Authors:  Anna-Lise Williamson
Journal:  J Clin Med       Date:  2015-04-02       Impact factor: 4.241

9.  Can Short-Term Use of Electronic Patient Adherence Monitoring Devices Improve Adherence in Patients Failing Second-Line Antiretroviral Therapy? Evidence from a Pilot Study in Johannesburg, South Africa.

Authors:  Denise Evans; Rebecca Berhanu; Faith Moyo; Arthemon Nguweneza; Lawrence Long; Matthew P Fox
Journal:  AIDS Behav       Date:  2016-11

10.  Alcohol use and depression: link with adherence and viral suppression in adult patients on antiretroviral therapy in rural Lesotho, Southern Africa: a cross-sectional study.

Authors:  Bernard Cerutti; Barbara Broers; Motlomelo Masetsibi; Olatunbosun Faturiyele; Likabelo Toti-Mokoteli; Mokete Motlatsi; Joelle Bader; Thomas Klimkait; Niklaus D Labhardt
Journal:  BMC Public Health       Date:  2016-09-08       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.